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NADPH and Glutathione Redox Link
TCA Cycle Activity to Endoplasmic
Reticulum Homeostasis
Erica R. Gansemer,1 Kyle S. McCommis,8,9 Michael Martino,8 Abdul Qaadir King-McAlpin,2
Matthew J. Potthoff,2,4,5,6 Brian N. Finck,8 Eric B. Taylor,3,4,5,6,7 and D. Thomas Rutkowski1,5,6,7,10,*
SUMMARY

Many metabolic diseases disrupt endoplasmic reticulum (ER) homeostasis, but little is known about how metabolic activity is communicated to the ER. Here, we
show in hepatocytes and other metabolically active cells that decreasing the
availability of substrate for the tricarboxylic acid (TCA) cycle diminished NADPH
production, elevated glutathione oxidation, led to altered oxidative maturation
of ER client proteins, and attenuated ER stress. This attenuation was prevented
when glutathione oxidation was disfavored. ER stress was also alleviated by inhibiting either TCA-dependent NADPH production or Glutathione Reductase.
Conversely, stimulating TCA activity increased NADPH production, glutathione
reduction, and ER stress. Validating these findings, deletion of the Mitochondrial
Pyruvate Carrier—which is known to decrease TCA cycle activity and protect the
liver from steatohepatitis—also diminished NADPH, elevated glutathione oxidation, and alleviated ER stress. Together, our results demonstrate a novel pathway
by which mitochondrial metabolic activity is communicated to the ER through the
relay of redox metabolites.
INTRODUCTION
As the gateway to the secretory pathway, the endoplasmic reticulum (ER) must properly synthesize and fold
nascent secretory and membrane proteins. Many disease states, including obesity and its comorbidities,
disrupt this process and cause ER stress (Mohan et al., 2019). Thus, it is important to understand how metabolic activity is communicated to the ER.
The ER and mitochondrial networks, although not connected to each other by secretory pathway traffic, are
intertwined both physically and functionally. The ER makes close physical contacts with mitochondria to
facilitate the exchange of metabolites (Raffaello et al., 2016; Vance, 2014; Yoboue et al., 2018). The ER
also communicates with mitochondria via signaling from the unfolded protein response (UPR), which is activated by ER stress and signals through the three ER-resident stress sensors IRE1, PERK, and ATF6 (Walter
and Ron, 2011). The UPR regulates mitochondrial activity at several levels, including enhancing mitochondrial protein quality control, augmenting ER-mitochondrial interactions and calcium signaling, and contributing to mitochondrial depolarization and initiation of apoptosis (Fan and Simmen, 2019; Gutierrez and
Simmen, 2018; Rainbolt et al., 2014). By these pathways, the mitochondria can respond to alterations in
ER homeostasis. However, the converse—how alterations in mitochondrial activity are transmitted to the
ER—is less understood.
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The impact of metabolic activity on ER homeostasis is most evident from the association of ER stress with
obesity—particularly in highly metabolically active tissues such as the liver, pancreas, and adipose (Cnop
et al., 2012). Lipotoxicity (i.e., damage caused by the inappropriate accumulation of lipids in non-adipose
tissue), inflammation, and oxidative stress have all been shown to contribute to obesity-associated ER
stress (Fu et al., 2012; Salvado et al., 2015). Yet, independent of diet content, feeding after a fast is sufficient
to elicit ER stress in the liver (Gomez and Rutkowski, 2016; Oyadomari et al., 2008; Pfaffenbach et al., 2010)
and to alter the extent of physical contacts between the ER and mitochondria (Theurey et al., 2016). These
findings suggest that ER homeostasis is acutely and intrinsically connected with metabolism even apart
from the problems brought on by obesity.
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The tricarboxylic acid (TCA) cycle is the central hub of metabolism, participating in both catabolism and
anabolism. Acetyl-CoA enters the cycle after either oxidative breakdown of fatty acyl-CoAs within the
mitochondria or after conversion from pyruvate—generated from glycolysis in the cytosol—by the mitochondrial pyruvate dehydrogenase complex. Canonically, TCA activity yields NADH and FADH2 for the
electron transport chain. However, the TCA cycle also provides precursors for biosynthetic pathways
(Owen et al., 2002). In addition, the cycle can produce NADPH through the activity of isozymes that reside
either in the mitochondria (isocitrate dehydrogenase [IDH] 2) or in the cytosol (IDH1 and malic enzyme/
ME1) (Rydstrom, 2006). Therefore, activity of the TCA cycle is likely to influence cellular processes by mechanisms beyond the production of ATP from the electron transport chain.
NADPH is used as a cofactor by Glutathione Reductase to reduce oxidized glutathione (GSSG/2GSH),
and likewise by thioredoxin reductase to reduce oxidized thioredoxin. Both these molecules contribute
to defense against oxidative stress (Sies et al., 2017), and both have connections to ER protein biogenesis.
Thioredoxin has been shown to be a source of electrons for reduction and isomerization of disulfide bonds
of ER client proteins (Poet et al., 2017). The oxidized form of glutathione (GSSG) was formerly thought to
reoxidize protein disulfide isomerase (PDI) in the ER lumen to promote ER disulfide bond formation. However, since the discovery of alternative pathways for PDI reoxidation (Frand and Kaiser, 1999; Tu et al., 2000;
Zito et al., 2010b), the role of glutathione in ER homeostasis is now much less clear (Delaunay-Moisan et al.,
2017; Tsunoda et al., 2014). Whether elevated GSSG might be beneficial to ER function under some cellular
conditions but detrimental in others is also unknown.
Despite the centrality of the TCA cycle to cellular function and hints that its activity might be tied to ER
stress (Mogilenko et al., 2019; Xin et al., 2018), a contribution to ER homeostasis has not been directly investigated. Here, we used primary hepatocytes and other metabolically active cell types to investigate the
relationship between mitochondrial metabolic activity and ER stress. We show that TCA cycle activity links
lipid and carbohydrate catabolism to ER homeostasis through production of NADPH and redox regulation
of glutathione. Our findings delineate a novel pathway by which mitochondrial metabolic activity is sensed
by the ER and suggest a role for GSSG in the process.

RESULTS
Inhibition of b-Oxidation Alleviates ER Stress in Metabolically Active Cell Types
We have previously shown in the liver and in hepatoma cells in vitro that inhibiting b-oxidation diminishes
ER stress signaling (Tyra et al., 2012). To identify the pathway by which b-oxidation and ER homeostasis are
linked, we first asked whether etomoxir (ET), which blocks b-oxidation by inhibiting the CPT1-dependent
transport of fatty acyl-CoAs into the mitochondria for oxidation (Weis et al., 1994; Yao et al., 2018), could
diminish ER stress signaling in primary hepatocytes in vitro as it does in the liver in vivo (see Transparent
Methods). Treatment of primary hepatocytes with the ER stressor tunicamycin (TM) upregulated UPRresponsive mRNAs, and ET cotreatment suppressed this effect (Figure 1A). A similar attenuation of UPR
signaling was seen after knockdown of Cpt1a (Figure S1A). Dampened ER stress signaling was also evident
from diminishment of the splicing of the IRE1a nuclease target Xbp1 (Figure 1B) and of the upregulation of
the stress-regulated factor CHOP (Figure 1C). Because these events are differentially regulated by the
three limbs of the UPR, our data suggest that ET attenuates signaling from all three UPR pathways.
We next determined if the apparent protective effects of ET were limited to one cell type or to one ER
stressor. Using the selection of UPR-regulated mRNAs in Figure 1A as an index of ER stress signaling,
we found that ET also diminished UPR activation in C2C12 myoblasts (Figure 1D) and immortalized (data
not shown) and primary (Figure 1E) brown adipocytes. Hepatocytes, myocytes, and brown adipocytes
are characterized by particularly high metabolic activity (Frayn et al., 2006), as adipose, skeletal muscle,
and particularly liver are among the top contributors to whole-body basal metabolic activity (Wang
et al., 2012). In contrast, ET had no significant effect on the expression of UPR target genes in primary
mouse embryonic fibroblasts (Figure S1B). In primary hepatocytes subjected to ER stress by palmitate
loading, ET likewise diminished ER stress signaling (Figure 1F). (As expected, the unsaturated fatty acid
oleate did not cause ER stress.) Palmitate is thought to elicit ER stress not by disrupting protein folding
per se but by altering ER membrane fluidity, activating the UPR stress sensors through their transmembrane
domains (Volmer et al., 2013). Thus, ET diminishes ER stress signaling induced by stressors that act by
distinct mechanisms.
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Figure 1. Inhibiting b-Oxidation Attenuates UPR Activity in Metabolically Active Cells and Protects against Different ER Stressors
(A–C) Mouse primary hepatocytes were treated with vehicle or 250 ng/mL tunicamycin (TM) in the presence or absence of 25 mg/mL ET (ET) for 8 h. Activation
of the UPR was assessed by qRT-PCR of a sampling of UPR target genes (A), splicing of Xbp1 by conventional RT-PCR (B), and CHOP protein expression by
immunoblot (C). In (B) and (C), and elsewhere, each lane represents an independently treated well. Loading control for immunoblot was calnexin, which does
not change in response to TM or ET.
(D and E) Same as (A) except using C2C12 mouse myoblasts (D) or mouse primary brown adipocytes (E).
(F) mRNA expression of UPR markers was assessed by qRT-PCR in primary hepatocytes treated with 200 mM palmitate (PA) or oleate (OA) and 25 mg/mL ET for
8 h. For this and subsequent figures error bars represent means G S.D.M. *p < 0.05, **p < 0.01, ***p < 0.001 by two-tailed t test and Benjamini-Hochberg
adjustment for multiple comparisons unless indicated otherwise. p values between 0.05 and 0.1 are given as values. NS, p > 0.1.
See also Figure S1.
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Figure 2. Inhibiting b-Oxidation Improves ER Ultrastructure
(A) Primary hepatocytes were treated with vehicle, 250 ng/mL TM, 25 mg/mL ET, or TM and ET for 8 h and fixed in 2.5% glutaraldehyde. Fixed cells were
imaged by transmission electron microscopy. Inset panels are indicated and shown on the right. Blue arrowheads represent areas of structurally normal ER,
whereas orange arrowheads represent dysmorphic ER. Scale bars, 2 mm.
(B) Images were scored blindly based on an approximation of the percentage of ‘‘dilated’’ ER in each image. Normal (blue): <25% of ER in an image dilated,
moderate (gray): 25%–75% dilated, and severe (orange): >75% dilated. Thus, the graph represents the percentage of images falling into each category. n =
9–10 cell images per group.
(C) Primary hepatocytes were treated with 25 mg/mL ET in the presence of 0.5, 2, or 10 mg/ml TM for 8 h, and expression of Bip and Chop was detected by
qRT-PCR. Note that the relative magnitude of UPR activation upon TM treatment varied from experiment to experiment, which is why induction of CHOP was
less robust at even the highest dose of TM in this experiment than in response to 0.25 mg/mL TM in Figure 1A.
See also Figure S2.

The effects of ET on ER stress signaling could be due to improvement of ER homeostasis in some way, or to
simple inhibition of UPR signaling. The first model predicts that ER homeostasis will be preserved by ET,
whereas the second predicts that it will be compromised, because impairment of the UPR is known to
aggravate ER stress (Walter and Ron, 2011). There are relatively few assays that are capable of examining
ER homeostasis apart from UPR signaling, but one such assay is the disruption of ER ultrastructure, which is
caused by ER stress and exacerbated when the UPR is compromised (e.g. Harding et al., 2001; Heazlewood
et al., 2008; Lee et al., 2005). Consistent with previous reports (Finnie, 2001; Rutkowski et al., 2006), TM elicited marked ER dilation accompanied by a loss of lamellar structure and overall disorganization, although
some areas of grossly normal ER were present and were predominantly juxtaposed near mitochondria. In
contrast, these disruptions were largely prevented by cotreatment with ET (Figure 2A) as confirmed by two
independent, blinded scorers (Figure 2B). Furthermore, although ET diminished ER stress signaling, it did
not block it entirely. Higher doses of TM elicited UPR activation in ET-treated cells to an extent comparable
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Figure 3. Stimulating Glutathione Oxidation Phenocopies Inhibition of b-Oxidation
(A) Primary hepatocytes were treated with 25 mg/mL ET or 25 mM 2-AAPA for 8 h. Levels of total (GSxtot), reduced (GSH),
and oxidized (GSSG) glutathione were measured fluorimetrically, and the ratio of GSSG to GSH was calculated. Values are
expressed relative to untreated cells.
(B and C) (B) Splicing of Xbp1 mRNA was measured by conventional RT-PCR, and (C) mRNA expression of UPR markers
was measured by qRT-PCR in cells treated for 8 h with TM and/or 2-AAPA.
(D) Levels of total, reduced, and oxidized glutathione were measured in primary hepatocytes treated with 10 mM auranofin
(AuF) for 8 h.
(E) mRNA expression of UPR markers after treatment with AuF for 8 h was quantified.

to that observed with lower doses in non-ET-treated cells (Figure 2C). Therefore, the UPR in ET-treated cells
remained competent for signaling. Together, these results suggest that inhibiting b-oxidation alleviates ER
stress. ET did not inhibit protein synthesis (Figure S2), suggesting that ET does not alleviate ER stress simply
by reducing the nascent ER client protein load.

Inhibiting b-Oxidation Protects ER Function through Glutathione Redox
We and others have previously shown that ET raises the cellular ratio of oxidized (GSSG) to reduced (GSH)
glutathione (Merrill et al., 2002; Pike et al., 2010; Tyra et al., 2012). To determine if glutathione redox plays a
role in the protective effects of ET, we used 2-Acetylamino-3-[4-(2-acetylamino-2-carboxy-ethylsulfanylthiocarbonylamino)phenylthiocarbamoylsulfanyl]propionic acid (2-AAPA) to inhibit Glutathione Reductase
(Seefeldt et al., 2009; Zhao et al., 2009), an enzyme with both mitochondrial and cytosolic activities that couples NADPH oxidation to GSSG reduction. We predicted that this treatment would phenocopy the protective effects of ET. As expected, treatment with 2-AAPA diminished cellular GSH levels and increased GSSG,
thus significantly elevating the GSSG/GSH ratio, similar to the effects of ET (Figure 3A). Also, similarly to ET,
2-AAPA treatment alleviated ER stress, as determined by attenuated Xbp1 splicing (Figure 3B) and diminished upregulation of UPR target genes (Figure 3C).
We next tested the converse prediction: that promoting glutathione reduction would cause ER stress. We
treated hepatocytes with auranofin, which inhibits redox-active selenoproteins, including thioredoxin reductases and, at the dose used here, glutathione peroxidases 1, 2, 3, 4, and 6 (Chaudiere and Tappel,
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1984; Roberts and Shaw, 1998; Scarbrough et al., 2012). Glutathione peroxidases generate GSSG through
the reduction of H2O2. In the liver, glutathione peroxidase 1 (GPX1) is two orders of magnitude more abundant than any thioredoxin reductase or other GPX (Lai et al., 2008). Auranofin treatment elevated cellular
GSH levels and diminished GSSG, leading to a decrease in the GSSG/GSH ratio (Figure 3D). Auranofin
treatment alone was sufficient to induce a modest level of ER stress, seen in upregulation of UPR target
genes in the absence of any other ER stress stimulus (Figure 3E).
Similar to 2-AAPA treatment, knockdown of Glutathione Reductase elevated the GSSG/GSH ratio (Figure S3A)
and diminished ER stress signaling (Figure 4A). 2-AAPA did not have any additional protective effect when
Glutathione Reductase was knocked down (Figure S3B), implying that the drug’s effects on ER stress were specific to Glutathione Reductase. 2-AAPA accentuated the protective effects of ET (Figure S3C). This effect might
be attributable to the more direct and rapid effects of 2-AAPA on the GSSG/GSH ratio compared with ET (Figure S3D). Even though 2-AAPA did not elevate the GSSG/GSH ratio above the effects of ET at the 8 h time point
(see Figure 4D), it is likely that the combination of 2-AAPA and ET would elevate the GSSG/GSH ratio at earlier
time points compared with ET alone, thus diminishing the early transcriptional induction of UPR targets, which
would still be evident when mRNAs were collected at 8 h. Alternatively, we cannot exclude that either ET or 2AAPA (or both) might mitigate ER stress partially through separate pathways.
As with auranofin, knockdown of GPX1 diminished the GSSG/GSH ratio (Figure S3A) and was sufficient to
cause ER stress (Figure 4B). Therefore, genetic manipulation of glutathione redox phenocopied the effects
of pharmacological manipulation on ER stress. Finally, auranofin blocked the ability of ET to alleviate ER
stress (Figure 4C) and also blocked the ET-induced elevation of the GSSG/GSH ratio (Figure 4D). Together,
these results show that ER homeostasis is sensitive to modulation of the GSSG/GSH ratio. As yet, whether
the ER senses these changes to glutathione directly or indirectly—for example, through the activity of other
codependent pathways such as the thioredoxin pathway—is not clear.

Inhibiting b-Oxidation Alters the Redox Maturation of ER Client Proteins
Given the association of GSSG with the oxidative protein folding environment in the ER, we examined whether
ET altered the oxidative state of client proteins in the ER lumen. This was done by monitoring the oxidation of
albumin, an endogenous hepatocyte protein that forms 17 disulfide bonds (Peters and Davidson, 1982). We
tested the resistance of albumin to reduction by treating cells with DTT, lysing them, and then modifying free
sulfhydryls with polyethylene glycol (PEG) maleimide, which retards migration on SDS-PAGE (Winther and
Thorpe, 2014). Albumin could not be modified by PEG maleimide in the absence of DTT, because nascent albumin is rapidly and quantitatively oxidized, so unoxidized or partially oxidized albumin is undetectable among
the steady-state pool (Peters and Davidson, 1982). Treatment with DTT led to almost complete reduction of albumin in otherwise untreated cells. However, ET caused a significant increase in the proportion of albumin that
remained oxidized (Figure 5A). These findings were mirrored by treating cells with 2-AAPA, which also rendered
albumin somewhat resistant to reduction, and contrasted by auranofin, which promoted reduction (Figure 5B).
These results suggest that ET makes the ER lumen relatively resistant to the reducing effects of DTT.
As a more direct measure of ER oxidation, we examined the processing of the endogenous ER client protein a1antitrypsin (a1AT) by pulse-chase and non-reducing electrophoresis. a1AT has a single unpaired cysteine residue. Treatment of cells with ET yielded an ~100-kDa species of a1AT (Figure 5C) that disappeared upon
reducing SDS-PAGE (data not shown), meaning that it is very likely an intermolecular a1AT disulfide-linked
dimer. Together, these results suggest that ET alters the oxidative modification of ER client proteins, even
though Glutathione Reductase is localized outside the ER.
The formation of intermolecular disulfide bonds has been associated with disease-causing misfolded alleles of human a1AT (Ronzoni et al., 2016; Ushioda et al., 2008), raising the possibility that ET might
compromise a1AT protein folding. Seemingly in support of this idea, our pulse chase revealed that a
greater percentage of a1AT chains in ET-treated cells were in the immature ER-localized form (confirmed
by EndoH-sensitivity; data not shown) at early times in the chase period (Figure 5C). However, by later chase
points essentially all a1AT chains had matured to the post-ER complex glycosylated form in the ET-treated
cells, such that by 5 h, comparable amounts of a1AT had matured in both groups (Figure 5C). Furthermore,
cotreatment of cells with the proteasome inhibitor MG-132 did not stabilize the immature ER-localized
form of a1AT or the disulfide-bonded dimer, suggesting that neither of these forms was terminally misfolded and degraded by proteasome-dependent ER-associated degradation (ERAD). Rather, it appeared
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Figure 4. Glutathione Oxidation Is Required for Inhibition of b-Oxidation to Alleviate ER Stress
(A) mRNA expression of Glutathione Reductase (Gsr) and UPR markers Bip and Chop was quantified in primary
hepatocytes transfected with a non-targeting control dsiRNA or either of two dsiRNAs targeting Gsr and treated for 8 h
with TM.
(B) mRNA expression of UPR markers was assessed in primary hepatocytes transfected with a non-targeting control
dsiRNA or dsiRNAs targeting Glutathione Peroxidase 1 (Gpx1).
(C) Hepatocytes were treated for 8 h with TM, ET, and/or AuF as indicated. mRNA expression of UPR markers was
measured by qRT-PCR.
(D) The effect of AuF or AAPA on the GSSG/GSH ratio in cells treated with TM and ET was measured and is expressed
relative to the ratio in untreated cells. For (D), significance was calculated by one-way ANOVA with Tukey honestly
signifiant differene (HSD) post-hoc test for comparisons.
See also Figure S3.
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Figure 5. Enhancing Glutathione Oxidation Influences ER Oxidative Protein Maturation
(A) Primary hepatocytes were treated with 25 mg/mL ET for 4 h followed by addition of 10 mM DTT for 0, 30, or 60 min.
Protein lysates were treated with 4 mM MM(PEG)24 (PEG-mal) before SDS-PAGE and immunoblotting to detect
endogenous albumin. The percentage of oxidized albumin is given below each group, with statistical comparison by t test
between ET-treated and non-treated cells.
(B) Hepatocytes were treated with 2-AAPA or AuF for 4 h before DTT and (PEG-mal) as in (A). Statistical comparisons were
by one-way ANOVA with Tukey post-hoc test.
(C) Hepatocytes were treated with vehicle or 25 mg/mL ET for 4 h, pulse labeled with 35S Met/Cys for 15 min, and chased in
complete hepatocyte medium with 5 mM unlabeled Met/Cys and containing vehicle or ET (and 5 mM MG-132 as
indicated). At lysis, N-ethyl maleimide (NEM) was added to block free thiols, and endogenous a1-antitrpysin was
immunoprecipitated from cell lysates. Samples were separated by non-reducing SDS-PAGE. The immature form (‘‘ER’’),
complex glycosylated form (‘‘post-ER’’), and disulfide-bonded dimer (‘‘S-S’’) are indicated.
(D) Hepatocytes were pretreated for 3 h 15 min with 25 mg/mL ET and/or 500 ng/mL TM and pulse labeled for 30 min with
35
S Met/Cys. Lysates were collected after the pulse, and media were collected after 3 or 8 h of chase with unlabeled Met/
Cys media containing TM and/or ET as indicated. For (C) and (D), each condition was performed in two independently
treated wells.
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Figure 6. Inhibiting b-Oxidation Attenuates ER Stress Induced by Overexpression of a Constitutively Misfolded
Protein
(A) Primary hepatocytes were infected with Ad-CMV-eGFP or Ad-TetOn-NHK at an MOI of 1. NHK expression was
induced with 500 ng/mL doxycycline (Dox) in the presence or absence of 25 mg/mL ET. mRNA expression of UPR markers
was measured by qRT-PCR after 8 h of treatment.
(B) Primary hepatocytes infected with Ad-TetOn-NHK and treated with Dox and/or ET for 8 h were fixed in 2.5%
glutaraldehyde for TEM. Orange arrowheads in insets denote dysmorphic ER. Images from which these insets were taken,
along with scale bars, are in Figure S4.
(C) Images were scored as described in Figure 2; n = 10 cell images per group.
(D) Primary hepatocytes infected with Ad-TetOn-NHK were treated with Dox and ET as in (A) for 4 or 8 h in the presence or
absence of 5 mM MG-132. NHK expression was analyzed by immunoblot. Loading control was calnexin.
See also Figure S4.

that ET delayed, but did not block, the anterograde maturation of a1AT through the secretory pathway.
This finding was supported by examining global protein secretion, again using a pulse chase. At early chase
points, ET diminished the appearance of radiolabeled proteins in the media both in cells treated with
vehicle and in cells treated with TM. However, by later chase points, this difference was lost (Figure 5D),
again suggesting that ET retarded, but did not block, secretory pathway protein processing.
We considered the possibility that diminished ER stress, improved ER ultrastructure, and delayed protein
maturation and secretion might together be explained by more stringent ER quality control. We therefore
examined the ability of ET to reverse ER stress associated with overexpression of the null Hong Kong (NHK)
protein. NHK is encoded by a frameshift mutation of a1AT that results in a truncated and terminally misfolded product that is retained in the ER and undergoes ERAD; its expression causes ER stress in diverse
cell types (Nagasawa et al., 2007; Ordonez et al., 2013; Sifers et al., 1988; Wu et al., 2007). We transduced
primary hepatocytes with a recombinant adenovirus expressing NHK in a doxycycline (Dox)-inducible
manner (Ad-TetOn-NHK). As a control, cells were transduced with adenovirus constitutively overexpressing GFP instead (Ad-GFP). No ER stress was observed in Ad-TetOn-NHK-transduced cells in the absence of
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Dox (not shown). As expected, Dox treatment elicited ER stress in cells transduced with Ad-TetOn-NHK,
but not in cells expressing Ad-GFP. The stress induced by NHK was markedly diminished by ET (Figure 6A).
Overexpression of NHK disrupted ER structure, resulting in the appearance of amorphous ER puncta that
were diminished by ET treatment (Figures 6B and S4). This finding was substantiated by blinded analysis of
electron microscopic images (Figure 6C). Furthermore, we observed an apparent enhancement of the
clearance of NHK by ERAD. Eight hours after induction (but not at 4 h), steady-state expression of NHK
was lower in ET-treated cells than in vehicle-treated cells, and this distinction was lost when degradation
of NHK was blocked by MG-132 (Figure 6D). Although the mechanisms by which ET enhances ERAD remain
under investigation, our results in Figures 5 and 6 point to effects of inhibiting b-oxidation—and by extension promoting glutathione oxidation—on ER protein oxidative maturation and quality control.

TCA Cycle Activity Links Oxidative Metabolism to ER Homeostasis
How is b-oxidation linked to glutathione redox? Glutathione Reductase requires NADPH to reduce glutathione, but b-oxidation yields NADH and FADH2 rather than NADPH. However, the end product of b-oxidation is acetyl-CoA, which enters the TCA cycle by condensation with oxaloacetate. We therefore speculated
that ET might diminish production of NADPH from the TCA cycle, thereby resulting in elevated GSSG. In
this model, it is not b-oxidation per se that is linked to ER homeostasis, but rather TCA cycle activity and the
resultant production of NADPH. This model first predicted that ET would diminish levels of both acetylCoA and NADPH—predictions that we then confirmed (Figures 7A and 7B). The model also predicted
that impairing TCA-dependent NADPH production would elevate the GSSG/GSH ratio and alleviate ER
stress, similarly to ET treatment. Three TCA cycle isozymes generate NADPH in the liver: mitochondrial
IDH2, cytosolic IDH1, and cytosolic ME1. Using dicer-substrate small interfering RNA (dsiRNAs), we specifically knocked down mRNA expression of each of these (Figure S5A), resulting in all cases in a surprisingly
robust diminishment of the NADPH/NADP+ ratio (Figure S5B). Knockdown of each gene also diminished
GSH levels, and knockdown of Idh2 and Me1 increased GSSG levels, thus elevating the GSSG/GSH ratio
(Figure 7C). Consistent with these results, each knockdown also alleviated ER stress (Figure 7D).
The Pyruvate Dehydrogenase complex oxidizes pyruvate produced by glycolysis to acetyl-CoA and is a major control point of TCA cycle activity for carbohydrate metabolism (Gray et al., 2014). Pyruvate Dehydrogenase Kinases (PDKs) phosphorylate and inactivate this enzyme complex. To determine the effects of
stimulating TCA cycle activity, we treated hepatocytes with dichloroacetate (DCA), which stimulates
substrate entry into the TCA cycle by inhibiting PDKs (Constantin-Teodosiu et al., 1999; Wu et al., 2018).
Dichloroacetate treatment substantially elevated the NADPH/NADP+ ratio (Figure 7E). In addition, DCA
treatment alone caused ER stress to an extent that was nearly as robust as the bona fide ER stressor TM,
as seen by splicing of Xbp1 (Figure 7F) and upregulation of UPR target genes (Figure 7G). Therefore, these
data provide direct evidence that mitochondrial oxidative catabolic activity causes ER stress, and that inhibiting production of NADPH by the TCA cycle alleviates ER stress.

Ablation of the Mitochondrial Pyruvate Carrier Alleviates ER Stress
Our results are consistent with a model whereby the production of NADPH by the TCA cycle links activity of
the cycle to ER oxidative protein maturation through glutathione. If this model is correct, then genetic manipulations that diminish TCA flux should confer resistance to ER stress. We tested this idea in cells lacking
the Mitochondrial Pyruvate Carrier (MPC). The MPC is composed of two subunits, MPC1 and MPC2, and
mediates mitochondrial import of pyruvate (Bricker et al., 2012; Herzig et al., 2012). Loss of either subunit
eliminates MPC activity, and liver-specific ablation of the MPC diminishes liver damage and inflammation in
mice on obesogenic diets (Gray et al., 2015; McCommis et al., 2015, 2017). In the absence of MPC activity,
import of pyruvate into the mitochondria is greatly diminished, meaning that less acetyl-CoA can be produced by Pyruvate Dehydrogenase and that TCA cycle flux is diminished (Gray et al., 2015; Rauckhorst
et al., 2017). We first examined the effects of deleting MPC1 by CRISPR in C2C12 myocytes (Oonthonpan
et al., 2019). We found that loss of MPC1 diminished the NADPH/NADP+ ratio and elevated the GSSG/
GSH ratio in these cells (Figures 8A and 8B). Diminished UPR activation at both the protein (Figure 8C)
and mRNA (Figure 8D) levels indicated that MPC1-deficient cells were remarkably resistant to ER stress
induced by TM or by the ER calcium-disrupting agent thapsigargin. These findings were confirmed in primary hepatocytes taken from mice lacking MPC2 in the liver (Mpc2LKO), when compared with cells from
mice with intact alleles (Mpc2fl/fl). In cells lacking MPC2, both the upregulation of UPR target genes (Figure 8E) and Xbp1 mRNA splicing (Figures 8F and 8G) were attenuated. These findings provide direct genetic evidence that ER homeostasis is responsive to the availability of TCA cycle substrates.
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Figure 7. ER Homeostasis Responds to TCA-Dependent NADPH Production
(A and B) (A) Acetyl-CoA levels or (B) the NADPH/NADP+ ratio was measured in primary hepatocytes treated with ET for
8 h. The NADPH/NADP+ ratio is expressed relative to untreated cells.
(C) Glutathione was quantified in cells with dsiRNA-mediated knockdown of Idh1, Idh2, or Me1 (first oligo pair from
Figure 7D in each case). A non-targeting dsiRNA was used as a control.
(D) Idh1, Idh2, or Me1 was knocked down as in (C) with either of two separate dsiRNAs before treatment with TM for 8 h.
Relative mRNA expression of Bip, Chop, and Derl3 was measured by qRT-PCR.
(E–G) Primary hepatocytes were treated with 4 mM dichloroacetate (DCA) or TM for 8 h. The NADPH/NADP+ ratio (E),
Xbp1 mRNA splicing (F), and UPR target gene expression (G) were analyzed as in previous figures.
See also Figure S5.
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Figure 8. Deletion of the Mitochondrial Pyruvate Carrier Alleviates ER stress
(A and B) The NADPH/NADP+ ratio (A) and the GSSG/GSH ratio (B) were measured as mentioned earlier in parental wildtype and Mpc1 / C2C12 myoblasts.
(C) Expression of UPR markers BiP, CHOP, phosphorylated eIF2a, and MPC1 was analyzed by immunoblot in wild-type
and Mpc1 / C2C12 myocytes treated with 100 ng/mL TM, 1 mg/mL TM, or 100 nM thapsigargin (TG). Loading control was
actin. Hairlines are for visual aid only.
(D) Relative mRNA expression of UPR markers from cells treated similarly to (C) was quantified by qRT-PCR.
(E) Primary hepatocytes from Mpc2fl/fl and Mpc2LKO mice were treated with 250 ng/mL TM, and gene expression was
measured by qRT-PCR.
(F) Splicing of Xbp1 in TM-treated hepatocytes from Mpc2fl/fl or Mpc2LKO mice was assessed by conventional RT-PCR. The
ordering of the second and third groups was rearranged by cut/paste to remain consistent with the rest of the data in the
article, but the image was otherwise unmodified.
(G) Xbp1 splicing was quantified from 8 independent samples (4 from cells taken from a male mouse, 4 from cells taken
from a female mouse).
(H) Model for how TCA cycle activity is linked to ER homeostasis.

DISCUSSION
Our results elucidate a pathway by which the ER senses mitochondrial metabolic activity (Figure 8H). We
propose that NADPH and GSSG convey TCA cycle status: decreasing the availability of acetyl-CoA—either
from lipid or carbohydrate catabolism—dampens NADPH production and disfavors glutathione reduction,
with the increased GSSG ultimately—either directly or indirectly—altering ER oxidative protein maturation
and protecting ER homeostasis. Conversely, enhancing acetyl-CoA availability ultimately favors GSH over
GSSG and causes ER stress. That these relationships were seen in hepatocytes, myocytes, and brown adipocytes, but were conspicuously absent in fibroblasts, hints that oxidative metabolism might represent an
intrinsic challenge to ER functionality and might explain why feeding itself appears to be an ER stressor.
Notably, proliferating fibroblasts exhibit high glycolytic activity and a high GSSG/GSH ratio, and very
low TCA activity, with cycle truncation before IDH activity (Lemons et al., 2010). Therefore, it is plausible
that inhibiting FAox when TCA activity is already low and GSSG already high has no further effect, potentially explaining why fibroblasts are refractory to protection by ET.
That ER stress accompanies increased TCA cycle activity does not necessarily signify cellular dysfunction. It
is possible that ER stress induced by enhanced metabolic activity might ‘‘prime’’ the ER by eliciting prophylactic ER stress. Brief exposures to stress are known to precondition cells against subsequent stresses (Rutkowski and Kaufman, 2007). Metabolic fluxes are, at least outside the context of overnutrition and obesity,
transient. Insulin action on the liver during feeding is known to promote both oxidative catabolism through
PDH dephosphorylation (Moule and Denton, 1997; Wieland et al., 1972) and protein biogenesis through
mammalian target of rapamycin activation (Howell and Manning, 2011). UPR activation induced by TCA
flux could enhance the functionality of the ER in anticipation of the increase in protein synthesis—including
synthesis of ER client proteins—that follows in the post-absorptive state.
Although our data suggest that production of NADPH by the TCA cycle is a key event in our proposed pathway,
it is not yet clear how NADPH production corresponds to actual activity of the cycle—given that metabolites can
enter and exit the cycle at multiple points depending on nutritional conditions—or how the cellular compartmentalization of NADPH production contributes to the transmission of the NADPH status to the glutathione
system. The NADPH/NADP+ ratio is regulated by nutritional state, exercise, diet, and circadian rhythms (Bradshaw, 2019; Ying, 2008). Only a portion of this NADPH is generated by the TCA cycle; other contributors include
the pentose phosphate pathway of glucose metabolism and one-carbon folate metabolism, both of which are
cytosolic. The fractional contribution of these pathways to total NADPH pools varies by cell type (Fan et al.,
2014). We found here that inhibition of either the mitochondrial (IDH2) or cytosolic (IDH1 and ME1) NADPH-producing enzymes diminished ER stress, and we have found previously that inhibition of the pentose phosphate
pathway does likewise (Tyra et al., 2012). These findings suggest that inhibiting NADPH production from any
source protects ER function. Moreover, the fact that knockdown of any single TCA-dependent NADPH-producing enzyme has such robust effects on the NADPH/NADP+ ratio (Figure S5B) suggests that these individual
pathways are interconnected in a way that is not yet clear. Furthermore, the fact that altering NADPH production either in the mitochondria or in the cytosol has the same effects on the GSSG/GSH ratio and on ER stress
points to mechanisms for transmission of NADP(H) and/or glutathione status across membranes. Whether this
exchange involves trans-mitochondrial transport of NADP(H) itself, or of glutathione, or of some other metabolite is not yet clear.
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A related question is how elevated GSSG in the mitochondria and/or cytosol is transmitted to the ER. Does
a change in the total cellular GSSG/GSH ratio ultimately change that ratio in the ER, or does GSSG exert its
effects on the ER environment indirectly, perhaps through the thioredoxin pathway, which also relies on
NADPH and which is functionally linked to glutathione redox (Miller and Schmidt, 2019; Toledano et al.,
2013)? To date, no mechanism for import of GSSG into the ER has been described. One possibility is
that diminishing the cytosolic level of GSH suppresses its import into the ER, thereby elevating the ER
GSSG/GSH ratio as well. However, given that the ratio of GSH to GSSG in the cytosol is approximately
100:1, it seems unlikely that cytosolic GSH is limiting in this way. Alternatively, perhaps sites of ER-mitochondrial contact facilitate spatially restricted exchange of glutathione as they do for other metabolites
such as calcium and reactive oxygen species (Joseph et al., 2019). Ultimately, determining how elevated
GSSG outside the ER alters ER oxidative protein maturation will require compartment-specific monitoring
and manipulation of the glutathione redox state.
Our results are surprising also in their implication that oxidized glutathione has a beneficial role for ER function. It is well established that reducing agents elicit robust ER stress and activate the UPR, which speaks to
the importance of the ER oxidative environment in the protein folding process. However, reducing
equivalents are needed as well, to activate the ER oxidase ERO1 (Kim et al., 2012) and to reduce disulfide
isomerases so that they can catalyze reduction of improper disulfide bonds (Schwaller et al., 2003). Disruption of this capacity impairs the secretory pathway transport of model proteins with non-sequential
disulfide bonds that must undergo such isomerization to avoid being trapped in non-native conformations
(Poet et al., 2017). This need for reducing power might account for the delayed maturation of secretory
client proteins that we observed in ET-treated cells (Figures 5C and 5D), although it appears to still allow
for eventual secretion. How oxidation and reduction are balanced within the ER lumen is not well understood, nor is it understood the extent to which a cell recognizes a hyperoxidizing ER lumen as a stress. It
is notable that treatments that favor ER oxidation such as diamide or overexpression of constitutively active
ERO1 elicit only modest ER stress (Hansen et al., 2012) (data not shown). The understanding of ER redox is
further confounded by the observations that neither ablation of both ERO1 isoforms (Zito et al., 2010a) nor
apparent depletion of ER glutathione (Tsunoda et al., 2014) appreciably impacts ER protein oxidation
capacity or stress sensitivity except for specialized substrates. Furthermore, because glutathione redox
homeostasis is tied to cysteine and glutamate levels, and glutamate feeds into the TCA cycle as a-ketoglutarate, TCA activity, ER homeostasis, and glutathione redox can also be connected through amino acid sufficiency. Perhaps exemplifying this point, inhibition of the cystine/glutamate exchanger results in activation
of an integrated stress response (but probably not a bona fide ER stress response) in cancer cells (Dixon
et al., 2014), and this response is activated by, among other stimuli, amino acid depletion (Donnelly
et al., 2013). We have observed that protein synthesis rates in ET-treated cells are particularly sensitive
to amino acid deprivation (data not shown), suggesting a link between ET treatment and amino acid pools
that might involve cysteine, glutamate, and glutathione. The relative importance of each of these pathways
to ER homeostasis might also vary by cell type.
Our results also raise the question of what aspect(s) of ER functional capacity are altered by TCA cycle activity and glutathione redox. Activation of the UPR generally serves as a readout for ER stress, but it is not
clear what diminished UPR signaling implies in terms of actual accumulation of unfolded proteins, particularly because some stressors, such as palmitate loading, activate the UPR apparently independent of the
protein folding process (Volmer et al., 2013). There are relatively few approaches for disentangling truly
dysfunctional protein processing from whatever criteria the UPR uses to perceive ER stress, which are still
not well understood. For example, one might expect a dysfunctional ER to secrete proteins more slowly.
On the other hand, perhaps enhanced ER retention time and chaperone association of client proteins facilitates proper protein folding under stressful conditions, which would be consistent with the delayed
secretion but diminished ER stress by ET that we observed. One intriguing—but speculative—possibility
is that GSSG might paradoxically protect the ER by exacerbating protein misfolding, if doing so renders
misfolded client proteins more readily recognized and either refolded or cleared rather than futilely
engaged with the ER quality control machinery. It will thus be interesting to test whether the protective effects of GSSG are negated by ablation of specific ER chaperones, trafficking factors, or ERAD components
that facilitate protein clearance. The redox status and activity of BiP will be of particular interest, given its
roles in protein folding, ERAD, protein translocation, and UPR signaling (Pobre et al., 2019), and the fact
that oxidative modifications can alter the nature of its associations with nascent proteins (Wang et al.,
2014) and with the translocation channel (Ponsero et al., 2017). Whatever the case, we infer that inhibiting
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TCA activity actually protects ER homeostasis in part because of its effects on ER ultrastructure. In principle,
a hyperoxidizing ER might simply blunt the UPR rather than improve ER function, because activation of at
least the UPR sensors ATF6 and IRE1 can be inhibited by oxidation (Nadanaka et al., 2007; Wang et al.,
2018). However, there is no evidence that enforcing reduction of these sensors is sufficient for their activation, meaning there would then be no reason to expect stimuli, such as DCA or GPX impairment, that
elevate GSH to activate the UPR on their own.
Although our findings extend to other cell types beyond hepatocytes, they seem particularly germane to
liver disease. Obesity is the leading cause of non-alcoholic fatty liver disease (NAFLD) which, along with its
downstream consequences—steatohepatitis, cirrhosis, and liver cancer—is the most common liver disease
in the world (Araujo et al., 2018). ER stress and dysregulation of the UPR are associated with NAFLD/nonalcoholic steatohepatosis (NASH) in humans (Gonzalez-Rodriguez et al., 2014; Lake et al., 2014; Lebeaupin
et al., 2015, 2018), and in mice on NASH-promoting diets (Charlton et al., 2011; Rahman et al., 2007). ER
stress might promote NASH by aggravating diet-induced steatosis (Lee et al., 2008; Oyadomari et al.,
2008; Rutkowski et al., 2008), and ER stress has also been shown to directly activate inflammatory signaling
cascades (Lebeaupin et al., 2018; Özcan et al., 2004; Willy et al., 2015) and to promote hepatocyte cell death
(Iracheta-Vellve et al., 2016; Olivares and Henkel, 2015). NAFLD is associated with increased TCA flux in the
liver (Rauckhorst et al., 2017; Satapati et al., 2012; Sunny et al., 2011), raising the question of whether NAFLD
progression is accelerated by ER stress arising from this increased flux, and whether diminished hepatic
TCA flux in mice lacking MPC activity protects the liver at least in part by alleviating or preventing ER stress.
On one hand, oxidative stress is recognized to contribute to NAFLD progression, and glutathione is known
to protect against NAFLD progression (Liu et al., 2015), although most of those studies have examined
glutathione synthesis rather than glutathione redox. On the other hand, our observation of elevated
GSSG in cells lacking MPC1 (Figure 8B) suggests that elevated GSSG is not incompatible with protection
from NAFLD. Whether TCA-dependent NADPH production contributes to NAFLD is not known. IDH1 and
IDH2 function in vivo has mostly been examined in the context of transforming mutations in gliomas that
change IDH activity. Both IDH1 and IDH2 are widely expressed, and to our knowledge no liver-specific
deletion of either has been created. Thus, the role of the axis identified here in NAFLD has not been directly
tested.
In conclusion, we have identified a novel NADPH- and glutathione-dependent pathway through which TCA
cycle activity impacts ER homeostasis. We expect that this pathway will be relevant to the physiology and
pathophysiology of liver, muscle, adipose, and other highly metabolically active cell types.

Limitations of the Study
This work was performed predominantly in mouse primary hepatocytes, with certain experiments also performed in immortalized myoblasts or in primary brown adipocytes. How our findings relate to other cell
types and to in vivo versus in vitro contexts is not yet clear. It is also likely that the effects of TCA cycle
manipulation on NADPH production will affect other NADPH-dependent pathways that have been implicated in ER homeostasis—particularly the thioredoxin pathway—in unforeseen ways. Last, although we
demonstrate that diminishing TCA cycle activity improves ER structure, diminishes UPR signaling, and alters secretory protein maturation, neither how protein folding and processing is altered nor how changes
to cytosolic glutathione redox are transmitted to the ER is clear yet. These are topics for future
investigation.

Resource Availability
Lead Contact
Further information and requests for resources and reagents should be directed to and will be fulfilled by
the Lead Contact, D. Thomas Rutkowski (thomas-rutkowski@uiowa.edu).

Materials Availability
All unique/stable reagents generated in this study are available from the Lead Contact upon request.

Data and Code Availability
This study did not generate large datasets. The published article contains all individual data points generated during the study.
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METHODS
All methods can be found in the accompanying Transparent Methods supplemental file.
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Figure S1. Additional effects of inhibition of β-oxidation, related to Figure 1. (A) Primary hepatocytes were transfected
with a control dsiRNA or either of two dsiRNAs against Cpt1a, and then treated with vehicle or TM as in Figure 1. (B)
Primary mouse embryonic ﬁbroblasts were treated with 25 μg/ml ET and 250 ng/ml TM as indicated for 8 h. mRNA
expression was assessed by qRT-PCR as in Figure 1.
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EasyTag ExpreSS35S (Perkin Elmer NEG772002MC) was added to a ﬁnal concentration of 50 μCi/ml. After the indicated
times, cell lysates were collected in 1% SDS 100 mM Tris, pH 8.8, denatured by heating, spotted onto gridded 3MM
ﬁlter paper, and air dried. Samples on the ﬁlter were then precipitated by serial incubations in ice-cold 10% trichloroacetic acid (TCA) for 60 min., 5% TCA at room temperature for 5 min., 5% TCA preheated to 75o for 5 min., 5% TCA at
room temperature for 5 min., and ﬁnally 2:1 ethanol:ether preheated to 37o for 5 min. Filter was then air dried, sliced
into individual samples, and immersed in scintillation cocktail, and counted. n = 6 samples per condition. The modest
effect of this dose of TM on protein synthesis is consistent with previous ﬁndings (Rutkowski et al., 2006).
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Figure S3. Manipulation of GSSG and GSH levels by knockdown, related to Figure 4. (A) Knockdown of Gsr, Gpx1, and Cpt1a produces the expected effects on
GSSG and GSH. (B, C) Gene expression was assesed in cells treated with the indicated combinations of inhibitors (TM, ET, AAPA) or dsiRNAs (Gsr) for 8 h. For all
knockdown experiments, non-targeting siRNA was used for control treatments. (D) AAPA elicits more rapid changes in the GSSG/GSH ratio than does ET.
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Figure S4. Improved ER structure by ET in NHK-expressing cells, related to Figure 6. Detailed EM images shown in
Figure 6B are taken from the images shown above.
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Figure S5. Effective and specific knockdown of TCA-dependent NADPH-producing enzymes, related to Figure 7. (A)
qRT-PCR confirmed specific decreases in mRNA expression of Idh1, Idh2, and Me1 using two independent pairs of
siRNAs for each gene, compared to cells transfected with a control siRNA. (B) Knockdown of any of these enzymes
diminished the relative NADPH/NADP+ ratio. As with changes in the UPR-dependent gene expression and the GSSG/GSH
ratio, effect sizes varied from one experiment to another but the trends remained consistent.

Transparent Methods
Cell culture and drug treatments
Primary hepatocytes were isolated from C57BL6/J mice of both sexes between 6-12 weeks of age. Mice were
anesthetized with isoflurane for the duration of the isolation. All animal experiments were approved by the University of
Iowa Institutional Animal Care and Use Committee. The liver was perfused through the portal vein with freshly prepared
Perfusion Medium followed by digestion with Liver Digest Medium. Media formulas were as follows: Liver Perfusion
Medium: HBSS, no calcium, no magnesium, no phenol red (Life Technologies, Carlsbad, CA), 0.5 mM EDTA, 0.5 mM
EGTA, 25 mM HEPES, and penicillin-streptomycin (10,000 U/mL); Liver Digest Medium: HBSS, calcium, magnesium, no
phenol red, 25 mM HEPES, penicillin-streptomycin (10,000 U/mL), 72 µg/ml Trypsin Inhibitor (Sigma, St. Louis, MO), 500
µg/ml Collagenase Type IV (210 U/mg) (Worthington Biochemical Corp., Lakewood, NJ). Flow rates were 4 ml/min for 5
min for perfusion, and 8 min for digestion. The liver was quickly excised, placed in cold Wash Medium (DMEM, 10 mM
HEPES, 5% FBS, 100 μg/mL penicillin-streptomycin), dispersed by tearing Glisson’s capsule, and filtered through a sterile
70 μm cell strainer. Hepatocyte suspensions were centrifuged at 500 rpm for 3 min and resuspended in 30 mL of Wash
Medium with 35% Percoll. Cells were centrifuged for 5 min at 1000 rpm, followed by resuspension in Wash Medium for a
final wash with centrifugation for 3 min at 500 rpm. Viable hepatocytes were resuspended in Hepatocyte Medium
(William’s E, 5% FBS, 10 nM insulin, 100 nM dexamethasone, 100 nM triiodothyronine, and 100 μg/mL penicillinstreptomycin), or, for Mpcfl/fl and liver-specific knockout (Mpc2LKO) hepatocytes, in high glucose DMEM, 10% FBS,
penicillin-streptomycin, and 0.5 µg/ml amphotericin B, and plated on collagen-coated tissue culture plates. Media was
changed 4 h after plating to remove any non-adherent cells. MPC2-deficient hepatocytes were isolated from Mpc2fl/fl
animals bred into the Albumin-CRE line. MPC1-deficient C2C12 cells were generated by CRISPR and cultured as
described (Oonthonpan et al., 2019). gRNA sequences were 5′-GCGCTCCTACCGGTGCCCGA-3′ and 5′GCCAACGGCACGGCCATGGC-3′.
For culture of primary BAT, interscapular brown adipose was removed from a litter of 4-6 day old C57BL6 pups,
with white adipose from this deposit removed. The remaining BAT was digested in collagenase (1 mg/ml in HBSS with 20
mg/ml BSA) for 90 minutes, followed by dispersion by repeated pipetting. Cells were place on ice for 15-30 min, and the
infranatant layer was passed through a 100 µm filter and pelleted at 700g for 5 min. iBAT stromal vascular cells (SVCs)
were resuspended in preadipocyte media (high glucose DMEM supplemented with 10% FBS, HEPES, Penn/Strep, 1x
non-essential amino acids, 1x GlutaMAX, and 100 nM b-mercaptoethanol) and plated on a 10 cm dish. After 3 days, cells
were replated on 12-well plates. Two days after confluency, cells were differentiated for four days with differentiation
media (high glucose DMEM, 10% FBS, Penn/Strep, 5 µg/ml insulin, 1 µM dexamethasone, and 0.5 mM IBMX). Cells were
then maintained in maintenance media (same as differentiation media without dexamethasone and IBMX) for
experiments. Primary mouse embryonic fibroblasts were isolated and cultured as described. Briefly, head, limbs, and
internal organs were removed from E12.5-14.5 embryos, and the remaining embryonic tissue was digested in 0.25%
trypsin-EDTA for approximately 30 minutes at 37°C until cells were separated. Trypsin was inhibited by addition of
complete medium, cells were pelleted at 1,000 rpm for 5 minutes, and cells were resuspended in MEF media (high
glucose DMEM supplemented with sodium pyruvate, L-glutamine, 10% FBS, Penn/Strep, 0.5x MEM amino acids, and 1x
non-essential amino acids). Drug treatments used the times and concentrations indicated in the figure legends. TM,
auranofin, and dichloroacetate (DCA) were from Millipore Sigma; ET, 2-AAPA, and MG-132 from Cayman Chemical;
stocks of each of these were stored at -20°C in DMSO, except for DCA which was made fresh for each use. Palmitic acid
and oleic acid (Millipore Sigma) were diluted stepwise in DMSO to 200 mM, and then to 100 mM in 10% fatty acid-free
BSA (Millipore Sigma), followed by incubation at 40°C for 90 min with gentle agitation. Uncomplexed BSA was used for
controls. Doxycycline (Millipore Sigma) stocks were stored at -20°C in water. All control samples received equivalent
vehicle controls.
For pulse-chase experiments, cells were labeled using an 35S Met/Cys labeling mixture at 200 µCi/ml (EasyTag
Express35S; Perkin Elmer) in media that contained drug treatments and that was 10 percent Hepatocyte Medium as
above and 90 percent high-glucose DMEM lacking Met/Cys and with dialyzed FBS. Labeling was stopped by addition of
Hepatocyte Medium with 5 mM Met/Cys, removal, and replacement of the same medium for the chase period. For
immunoprecipitations, chases were stopped in ice-cold HBSS with 20 mM N-ethylmaleimide, and lysates were collected in
0.5% Triton-X100, 100 mM HEPES pH 7.5, 100mM NaCl, 1 mM EDTA, 20 mM NEM, 1 mM PMSF, and a protease
inhibitor tablet (Roche). Samples were centrifuged at 12,000 rpm for 5 minutes at 4°C and endogenous a1-antitrypsin was
immunoprecipitated using a commercially-available antibody (Dako A0012) that recognizes mouse a1AT by
immunoprecipitation (but not by immunoblot). Immunoprecipitations were separated by non-reducing or reducing SDSPAGE as indicated in the figure legends and dried gels were exposed to Biomax MS film (Carestream Health) using an
enhancer screen.
Adenovirus experiments
A cDNA encoding the NHK allele of a1-antitrpysin was cloned into an adenoviral shuttle vector downstream of a TRETight promoter, and the shuttle was recombined with a backbone expressing rtTA under the RSV promoter. Virus was
purified by the University of Iowa Viral Vector Core. Primary hepatocytes were infected with Ad-TetOn-NHK or Ad-CMVeGFP at a multiplicity of infection of 1:1. Infection began when media was changed 4 h after cells were plated. Cells were

incubated with adenovirus for at least 12 h prior to addition of doxycycline or other treatments. NHK expression was
induced with 500 ng/mL doxycycline in fresh media at the time of treatment.
dsiRNA knockdown experiments
Primary hepatocytes were cultured overnight prior to transfection. Hepatocytes were transfected with 2.75 µM dsiRNA
(Integrated DNA Technologies, Coralville, IA) in nuclease-free duplex buffer using the Viromer Blue transfection kit
(Origene) following the manufacturer’s protocol. A non-targeting dsiRNA was used as a control, and two dsiRNAs for each
gene of interest (Idh1, Idh2, Me1, Gpx1, Gsr, and Cpt1α) were used. Hepatocytes were transfected with dsiRNA for 24 h
before experimental treatments. Targeting sequences were as follows: Idh1: GUACAACCAGGAUAAGUCAAUUGAA,
GUUGAAGAAUUCAAGUUGAAACAAA; Idh2: AUUUAUAUUGCUCUGGAAUCACATG,
AUCUUUGACAAGCACUAUAAGACTG; Me1: GCCAUUGUUCAAAAGAUAAAACCAA,
ACCUUUCUAUCAGAUAUUAAAAUAT; Gpx1: GGUGGUUUCACUACUAAGAAUAAAG,
GUUCGAGCCCAAUUUUACAUUGUTT; Gsr: GGCAUGAUAAGGUACUGAGAAAUTT,
CAGAAGAACUUAUGUAUCUAAUCAG; Cpt1a: AUCUGUCCAUUGCAUGUAAAUACCA,
GUGUGAUAUCAUCCAUGCAUACCAA;
non-targeting control: CGUUAAUCGCGUAUAAUACGCGUAT
Biochemical Assays
Levels of total (GSx), oxidized (GSSG), and reduced (GSH) glutathione were measured using a Glutathione Fluorometric
Assay Kit (Biovision, Milpitas, CA) following the manufacturer’s protocol. NADPH levels were measured using an
NADP/NADPH Colorimetric Quantification Kit (Biovision), and acetyl-CoA levels using the PicoProbe™ Acetyl-CoA
Fluorometric Assay Kit (Biovision) following the manufacturer’s protocols. For all experiments, cells were lysed directly in
ice-cold Glutathione Assay Buffer, NADPH Assay Buffer, or Acetyl-CoA Assay Buffer, incubated on ice with 6N perchloric
acid, centrifuged to remove precipitates, and the supernatants were stored at -80°C. Perchloric acid was neutralized with
potassium hydroxide prior to measurements.
RNA and Protein Analyses
Protein lysates were processed for immunoblot as described (Rutkowski et al. 2006). Primary antibodies were: CHOP
(Santa Cruz sc-7351 or Proteintech 15204-1-AP), BiP (BD Biosciences 610978), PeIF2a (ThermoFisher 44-728G), MPC1
(Cell Signaling Technology 14462), calnexin (loading control; Enzo ADI-SPA-865), actin (loading control; MP Biomedicals
691001), a1-antitrypsin (Dako A0012). The oxidative state of the ER was measured by incorporation of PEG-mal
(mm(PEG)24) (ThermoFisher). Cells were rinsed twice in PBS, lysed in 2% SDS 100 mM Tris pH 6.8, heated to 100°C for
15 minutes, and equal aliquots were treated with PEG-mal or DMSO for 20 minutes at 37°C. Reaction was quenched with
100 mM DTT. Samples were run on Tris-tricine or Tris-HCl SDS-PAGE gels and transferred to 0.45 µm Immobilon-P
Polyvinylidene Fluoride (PVDF) (Millipore) for Western blotting using ECL Prime substrate (GE Healthcare). Blots were
imaged on Hyperfilm ECL and quantified by densitometric scanning from the images shown. qRT-PCR, including primer
validation by standard curve and melt curve analysis, was as described (Rutkowski et al., 2006). Briefly, RNA was isolated
following the standard Trizol protocol and RNA concentrations were obtained using the Qubit RNA Broad Range kit.
Concentrations were normalized, and cDNA was synthesized using 400 ng RNA with PrimeScript RT Master Mix
(Takara). PCR reactions were performed using TB Green Premix Ex Taq (Takara) in a CFX96 cycler (Bio-Rad).
Oligonucleotide sequences are listed below. Gene expression was normalized against the average of two loading controls
(Btf3 and Ppia). Conventional RT-PCR was performed to assess splicing of Xbp1 using Superscript III RT One-Step with
Platinum Taq (ThermoFisher) according to the manufacturer’s protocol. The size of the amplified product was 198 bp for
unspliced Xbp1 mRNA and 172 bp for spliced. Oligonucleotide sequences were as follows:
Gene
Sequences
Btf3 (loading)
Fwd: CCAGTTACAAGAAAGGCTGCT
Rev: CTTCAACAGCTTGTCCGCT
Ppia (loading)
Fwd: AGCACTGGAGAGAAAGGATT
Rev: ATTATGGCGTGTAAAGTCACCA
Bip
Fwd: CATGGTTCTCACTAAAATGAAAGG
Rev: GCTGGTACAGTAACAACTG
Chop
Fwd: CTGCCTTTCACCTTGGAGAC
Rev: CGTTTCCTGGGGATGAGATA
Derl3
Fwd: TGGGATTCGGCTTCTTTTTC
Rev: GAACCCTCCTCCAGCAT
Edem
Fwd: CGATCTGGCGCATGTAGATG
Rev: AAGTCTAGGAGCTCAGAGTCATTAA
Dnajc3
Fwd: TCCTGGTGGACCTGCAGTACG
Rev: CTGCGAGTAATTTCTTCCCC
Xbp1
Fwd: TTGTGGTTGAGAACCAGG
Rev: TCCATGGGAAGATGTTCTGG
Cpt1a
Fwd: GCTGGGCTACTCAGAGGATC

Gpx1
Gsr

Rev: CACTGTAGCCTGGTGGGTTT
Fwd: GGACTACACCGAGATGAACG
Rev: TCGGACGTACTTGAGGGAAT
Fwd: ATCCCTACTGTGGTCTTCAGC
Rev: GGGGTAAAGGCAGTCGAGTA

Transmission Electron Microscopy
Primary hepatocytes were cultured on collagen-coated glass coverslips. Cells were washed in DPBS and fixed overnight
at 4°C in 2.5% glutaraldehyde while protected from light. Cells were processed and imaged by the University of Iowa
Central Microscopy Research Facility. Processing included 1% osmium fixation, incubation in 2.5% uranyl acetate, serial
washes increasing from 50 to 100% ethanol, 2:1 ethanol and Epon (1 h), 1:2 ethanol and Epon (1 h), 100% Epon
overnight, embedding in fresh Epon at 70°C for 24-48 h, microtomy, and uranyl/lead staining. Images were acquired on a
JEOL JEM-1230 Transmission Electron Microscope. TEM images were scored blindly and binned into categories based
on the percentage of ER morphology in each image that was dysmorphic. Bins were as follows: Normal (<25% of ER in
an image was dysmorphic), Intermediate (25-75% dilated), or Severe (>75% dilated).
Statistical Analyses
Continuous variables were reported as the mean ± standard deviation and pairwise comparisons were analyzed using the
two-tailed Student’s t-test with Benjamini-Hochberg post-hoc correction for multiple comparisons (i.e., multiple genes from
the same experiment). For comparisons of multiple groups, one-way ANOVA was used with Tukey’s HSD post-hoc
analysis. For qRT-PCR, significance was calculated prior to transformation of Ct values out of the log phase. A postcorrection alpha of 0.05 was used to determine statistical significance.

